Literature DB >> 9607020

Comparison of DNA application methods to reduce BRSV shedding in cattle.

R S Schrijver1, J P Langedijk, G M Keil, W G Middel, M Maris-Veldhuis, J T Van Oirschot, F A Rijsewijk.   

Abstract

We compared the protection afforded by three different DNA application methods against bovine respiratory syncytial virus (BRSV) infection in cattle. A synthetic gene that codes for the G protein of BRSV was inserted into a eukaryotic vector and was used in the vaccine. Intradermal (i.d.) application with a needleless injector (NI), the Pigjet, reduced BRSV excretion significantly better after BRSV challenge than intramuscular (i.m.) or i.d. vaccination with a needle. Serum antibodies against the G protein were consistently the highest and showed less variation in Calves vaccinated with the NI compared with those in i.m. and i.d. vaccinated calves. After BRSV challenge, secondary serum and mucosal antibody responses were also the highest in NI vaccinated calves. We conclude that DNA application with the needleless injector is substantially better than i.m. or i.d. application, and is capable to prime the immune response at the respiratory mucosa.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9607020     DOI: 10.1016/s0264-410x(97)00198-9

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

1.  DNA vaccine construct incorporating intercellular trafficking and intracellular targeting motifs effectively primes and induces memory B- and T-cell responses in outbred animals.

Authors:  Waithaka Mwangi; Wendy C Brown; Gary A Splitter; Christopher J Davies; Chris J Howard; Jayne C Hope; Yoko Aida; Yan Zhuang; Beverly J Hunter; Guy H Palmer
Journal:  Clin Vaccine Immunol       Date:  2007-01-10

2.  DNA immunization with plasmids encoding fusion and nucleocapsid proteins of bovine respiratory syncytial virus induces a strong cell-mediated immunity and protects calves against challenge.

Authors:  Mathieu Boxus; Marylène Tignon; Stefan Roels; Jean-François Toussaint; Karl Walravens; Marie-Ange Benoit; Philippe Coppe; Jean-Jacques Letesson; Carine Letellier; Pierre Kerkhofs
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

3.  Efficacy of mucosal polyanhydride nanovaccine against respiratory syncytial virus infection in the neonatal calf.

Authors:  Jodi L McGill; Sean M Kelly; Pankaj Kumar; Savannah Speckhart; Shannon L Haughney; Jamie Henningson; Balaji Narasimhan; Randy E Sacco
Journal:  Sci Rep       Date:  2018-02-14       Impact factor: 4.379

Review 4.  Advances in RNA Vaccines for Preventive Indications: A Case Study of A Vaccine Against Rabies.

Authors:  Nicole Armbruster; Edith Jasny; Benjamin Petsch
Journal:  Vaccines (Basel)       Date:  2019-09-27

5.  Immunofluorescence and molecular diagnosis of bovine respiratory syncytial virus and bovine parainfluenza virus in the naturally infected young cattle and buffaloes from India.

Authors:  Bhupesh Kamdi; Rajendra Singh; Vidya Singh; Shailendra Singh; Pawan Kumar; Karam Pal Singh; Neethu George; Kuldeep Dhama
Journal:  Microb Pathog       Date:  2020-03-20       Impact factor: 3.738

6.  Vaccination of calves using the BRSV nucleocapsid protein in a DNA prime-protein boost strategy stimulates cell-mediated immunity and protects the lungs against BRSV replication and pathology.

Authors:  Carine Letellier; Mathieu Boxus; Laurent Rosar; Jean-François Toussaint; Karl Walravens; Stefan Roels; Gilles Meyer; Jean-Jacques Letesson; Pierre Kerkhofs
Journal:  Vaccine       Date:  2008-07-21       Impact factor: 3.641

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.